Christopher Nadorff, M.D.: DEA registration order
Oct 11, 2026 edition · GC-2026-0187 · Published 2026-10-11 · Version 4 · Final
DEA’s final Nadorff order follows an Ohio medical-license suspension already in force since October 2025. The federal order revokes the named registration and denies related pending Ohio applications effective October 29. That future date does not restore the underlying state authority.
What happened
DEA’s final decision revokes registration FN4962761 issued to Christopher Nadorff, M.D., and denies pending renewal, modification and additional Ohio registration applications. The order was signed September 21, published September 29 and is effective October 29, 2026. Its factual basis is loss of state authority: the State Medical Board of Ohio suspended the physician’s medical license effective October 8, 2025, and the state records noticed by DEA continued to show suspension when the order was signed.
The physician defaulted in the administrative proceeding, and DEA treated the factual allegations as admitted. The decision establishes the license suspension and its consequences for federal registration; it does not supply findings about the underlying conduct that caused the state suspension. Because the state restriction already existed, the later federal effective date is not an interim permission to practice or handle controlled substances. Credentialing teams should distinguish a professional-license restriction, the DEA registration decision and any independently verified later change in status, rather than infer reinstatement from the passage of time.
Scope and timing
- Authority status
- Final
- Applicability
- Operationally relevant
- Audience
- Health systems, Provider networks
- Jurisdiction
- Federal
- Recorded date
- 2026-10-29
- Date type
- effective
Why it matters
The action identifies a control failure relevant to provider, payer or vendor oversight. Its procedural status must be kept separate from any allegation.
Recommended action
Verify the physician’s Ohio license and DEA status separately and account for the earlier suspension. Obtain actual evidence of any later reinstatement or stay instead of assuming authority until the federal order takes effect.
Case details
- agencies
- Drug Enforcement Administration
- entities
- Christopher Nadorff, M.D.
- action Type
- Administrative order
- event Date
- 2026-09-21
- alleged Conduct
- DEA administrative registration eligibility and public-interest findings stated in the final order.
- resolution
- Final administrative order. Effective October 29, 2026.
Operational lessons
- Check controlled-substance authority independently of professional licensure, and review counterparties implicated by the specific order.
Sources
- Christopher Nadorff, M.D.; Decision and OrderOfficial · Justice Department, Drug Enforcement Administration · 2026-09-29 · Source review 2026-10-11
Complete edition and supplemental material
This finding in the complete approved report →Regulatory horizons, CIA trends and implementation trackers remain in the full report.
Read the entire Enforcement Briefing report →